Amendment to Rule 10b5-l Trading PlanTroendle August J. • September 13th, 2022 • Services-commercial physical & biological research
The Trading Plan dated 3/17/2022 and amended 5/3/2022 (the “Trading Plan”) entered into between Medpace Investors LLC (“Purchaser”) and UBSFS, acting as agent, for the purpose of establishing a trading plan that complies with Rule 10b5-1(c)(1) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) is amended on August 15, 2022 as follows, with the consent of UBSFS:
